Keyphrases
Tuberculosis
100%
Population Pharmacokinetics
100%
Rifampicin
100%
Mexican Patients
100%
Pharmacokinetic Parameters
50%
Lag Time
50%
Population Pharmacokinetic Model
50%
Pharmaceutical Formulations
50%
Pharmacokinetics
25%
Plasma Concentration
25%
Clinical Practice
25%
Relative Bioavailability
25%
Demographic Characteristics
25%
Clinical Characteristics
25%
Time-varying Data
25%
First-order
25%
Intraindividual Variability
25%
Volume of Distribution
25%
Parameter Estimation
25%
Time of Concentration
25%
Final Model
25%
One-compartment Model
25%
Validation Data
25%
Time Order
25%
Dose Adjustment
25%
Residual Variability
25%
Absorption Rate Constant
25%
Nonlinear Mixed Effects
25%
Absorption Phase
25%
TB Patients
25%
Anti-tuberculosis Therapy
25%
Potential Influence
25%
Pharmacology, Toxicology and Pharmaceutical Science
Rifampicin
100%
Pharmacokinetics
100%
Pharmacokinetic Parameter
50%
Elimination
25%
Prospective Study
25%
Bioavailability
25%
Volume of Distribution
25%